Global Transcatheter Embolization And Occlusion Devices Market Size
Medical Equipment

Understand How The Transcatheter Embolization And Occlusion Devices Market Is Poised To Grow Through 2024-2033

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Transcatheter Embolization And Occlusion Devices Global Market Report 2024, the transcatheter embolization and occlusion devices market is expected to show significant growth in the forecast period.

Rapid Market Expansion
The transcatheter embolization and occlusion devices market has experienced significant growth recently. The market size, valued at $4.31 billion in 2023, is expected to rise to $4.76 billion in 2024, reflecting a compound annual growth rate (CAGR) of 10.4%. This increase is driven by several factors:

  • Expansion of the target patient population
  • Rise in minimally invasive vascular surgeries
  • Growing incidence of vascular and chronic diseases
  • Demand for effective treatment options

Forecasted Market Growth
Looking ahead, the market is projected to reach $7.13 billion by 2028, with a CAGR of 10.6%. This anticipated growth is attributed to:

  • Increased research and development activities
  • Expansion of the healthcare sector
  • Growing adoption of minimally invasive techniques
  • Rising older population
  • Increased workshops and awareness initiatives

View More On The Transcatheter Embolization And Occlusion Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Key trends influencing this period include:

  • Technological advancements
  • Improved imaging techniques
  • Integration of artificial intelligence and machine learning
  • Ongoing improvements in device design and delivery systems

Minimally Invasive Surgery Driving Demand
Minimally invasive surgical techniques are significantly propelling the growth of the transcatheter embolization and occlusion devices market. These techniques use small incisions or natural openings to minimize trauma, offering benefits such as:

  • Reduced invasiveness
  • Shorter recovery times
  • Localized treatment
  • Less pain
  • Lower risk of complications
  • Potential for outpatient procedures

For instance, Intuitive Surgical Inc. reported that in 2022, around 1,875,000 surgeries were performed with Vinci systems, marking an 18% increase from the previous year. This growing preference for minimally invasive techniques is driving market expansion.

Technological Advancements
Major companies in the market are focusing on technological innovations to stay competitive. Advanced features such as multi-catheter compatibility enhance versatility and efficiency in procedures. Notable advancements include:

  • Boston Scientific’s EMBOLD Fibered Detachable Coil: Received FDA clearance in April 2022, designed for embolization in peripheral vasculature. This device features multi-catheter compatibility and a nitinol delivery system to streamline procedures and reduce complications.

Strategic Acquisitions
Boston Scientific’s acquisition of Obsidio Inc. in August 2022 exemplifies strategic moves to strengthen their embolization portfolio. Obsidio Inc. is known for its novel transcatheter embolic hydrogel (GEM) designed for minimally invasive delivery. This acquisition enhances Boston Scientific’s offerings in interventional oncology and embolization.

Market Segmentation
The transcatheter embolization and occlusion devices market is segmented as follows:

  1. By Type: Coil, Non-Coil
  2. By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
  3. By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users

Regional Insights
In 2023, North America was the leading region in the transcatheter embolization and occlusion devices market. The region’s dominance is attributed to advanced healthcare infrastructure, high prevalence of vascular diseases, and significant investment in medical technologies.

Conclusion
The transcatheter embolization and occlusion devices market is poised for substantial growth, driven by advancements in technology, increasing demand for minimally invasive procedures, and strategic industry developments. As the market evolves, continued innovation and strategic acquisitions will play a crucial role in shaping its future.

Request A Sample Of The Global Transcatheter Embolization And Occlusion Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15944&type=smp